Uterine Cavity Volume Measuring With Sonohysterography: A New Objective Method
1 other identifier
observational
185
1 country
1
Brief Summary
Measuring of uterine cavity volume using sonohysterography will be done in two groups of patients, Group A included 35 patients for home hysterectomy were indicated and group B includes 150 infertile patients in the childbearing age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2018
CompletedFirst Posted
Study publicly available on registry
December 17, 2018
CompletedStudy Start
First participant enrolled
February 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedDecember 23, 2019
December 1, 2019
10 months
December 14, 2018
December 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
calculation of uterine cavity volume with an objective method
measuring uterine cavity volume objectively
one day
Study Arms (2)
group A
35 patients with an indication for hysterectomy without gross uterine pathology
group B
150 infertile patients in the childbearing age without gross uterine pathology
Interventions
sonohysterography with measuring the uterine cavity volume
Eligibility Criteria
Women undergo sonohysterography for gynecologic indication without gross uterine pathology.
You may qualify if:
- Patients without any gross pathology within the uterus.
- Patients admitted for hysterectomy.
- Patients agreed with written consent to participate in the study.
You may not qualify if:
- Virgins.
- Pregnancy.
- Systemic blood disease.
- Any clinical evidence of cervical, uterine or tubal infection.
- Refusal to undergo saline infusion sonography.
- Any gross uterine pathology diagnosed clinically or with sonography.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AIn Shams University Maternity Hospital
Cairo, 11357, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed I Amer, MD
Ain Shams University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 14, 2018
First Posted
December 17, 2018
Study Start
February 10, 2019
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
December 23, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share